Huntsman
Huntsman's revenue fell 5.8% to $5.7 billion in fiscal 2025. Its operating margin was −2.3%, down from −0.4% a year earlier. Free cash flow was $116 million, up 46.8%. It paid out $146 million in dividends and buybacks, 126% of free cash flow. The diluted share count rose 0.3%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2023, earnings per share fell 11.7% a year and net income 15.4% a year, while buybacks cut the share count by 26%. Huntsman then lost money in fiscal 2024 and 2025.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Huntsman yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Huntsman's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Huntsman's fiscal 2025 free cash flow of $116M, net cash of −$1.6B at December 31, 2025 and 173 million diluted shares, from its filings. The scenarios are fitted to Huntsman: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -10.9% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 13%: 11% for a cyclical or higher-risk business (Specialty Chemicals), plus 1 point as a smaller company, worth $1.5B, plus 1 point for unsteady results (a loss in fiscal 2025); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target. A negative value means Huntsman's net debt is larger than what that scenario's cash flows are worth today.
- Last close, October 26, 2026
- $8.89
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
The P/E method needs positive earnings, and Huntsman's latest diluted earnings per share were negative or zero.
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1,041 | 654 | 540 | 340 | 429 |
| Debt incl. finance leases | 1,550 | 1,737 | 1,688 | 1,835 | 2,011 |
| Net debt (negative means net cash) | 509 | 1,083 | 1,148 | 1,495 | 1,582 |
| Net debt to EBITDA | 0.5x | 1.1x | 3.2x | 5.7x | 10.1x |
| Debt to equity | 0.3x | 0.5x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 8.9x | 10.2x | 1.2x | −0.3x | −1.5x |
| Current ratio | 1.9x | 1.9x | 2.0x | 1.4x | 1.3x |
| Quick ratio | 1.4x | 1.3x | 1.2x | 0.8x | 0.8x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $1.2 million of Huntsman shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Peter R HuntsmanChairman, President & CEO, Director | Bought | 100,000 | $9.81 | $981,000 | Form 4 |
| Nov 10, 2025 | Philip M. ListerExec VP & CFO | Bought | 29,762 | $8.16 | $242,858 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Fail | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Pass | Pass | Fail |
| Gross margin rose | Fail | Fail | Fail |
| Revenue rose relative to assets | Fail | Pass | Fail |
| F-score | 5 of 9 | 4 of 9 | 2 of 9 |
| Accruals ratio | −1.4% | −6.3% | −8.1% |
Compare
Put Huntsman side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Huntsman | FY25 | −5.8% | −2.3% | 2.0% | −2.2% | 10.1x | 2 | |
| Albemarle | FY25 | −4.4% | −7.1% | 13.5% | −2.4% | 5.8x | 7 | Compare |
| Axalta | FY25 | −3.0% | 14.4% | 8.8% | 10.5% | 2.5x | 7 | Compare |
| RPM International | FY26 | 6.7% | — | 8.6% | 13.9% | 1.9x | 6 | Compare |
| Solstice Advanced Materials | FY25 | 3.1% | — | 3.1% | 12.2% | 2.3x | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 7,518 | 6,845 | 7,604 | 6,797 | 5,421 | 7,670 | 8,023 | 6,111 | 6,036 | 5,683 |
| Revenue growth | −7.6% | −8.9% | 11.1% | −10.6% | −20.2% | 41.5% | 4.6% | −23.8% | −1.2% | −5.8% |
| Gross profit | 1,518 | 1,651 | 1,764 | 1,382 | 977 | 1,584 | 1,546 | 906 | 866 | 751 |
| Research and development | 137 | 132 | 145 | 137 | 121 | 135 | 125 | 115 | 121 | 120 |
| Operating income | 663 | 729 | 827 | 469 | 432 | 731 | 672 | 84 | −25 | −131 |
| Net income | 326 | 636 | 337 | 562 | 1,034 | 1,045 | 460 | 101 | −189 | −284 |
| Diluted EPS (US$) | 1.36 | 2.61 | 1.39 | 2.44 | 4.66 | 4.72 | 2.27 | 0.57 | −1.10 | −1.65 |
| Diluted shares (millions) | 240 | 244 | 242 | 231 | 222 | 221 | 203 | 177 | 172 | 173 |
| Cash flow | ||||||||||
| Cash from operations | 1,088 | 1,219 | 1,207 | 897 | 253 | 952 | 914 | 209 | 263 | 289 |
| Capital expenditure | 318 | 234 | 251 | 274 | 237 | 326 | 272 | 230 | 184 | 173 |
| Free cash flow | 770 | 985 | 956 | 623 | 16 | 626 | 642 | −21 | 79 | 116 |
| Dividends paid | 120 | 120 | 156 | 150 | 144 | 159 | 171 | 169 | 174 | 146 |
| Share buybacks | 0 | 0 | 277 | 208 | 96 | 200 | 1,005 | 349 | 4 | 0 |
| Acquisitions | 0 | 14 | 366 | 0 | 650 | 245 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 32 | 36 | 27 | 29 | 26 | 30 | 29 | 28 | 30 | 31 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 385 | 470 | 340 | 525 | 1,593 | 1,041 | 654 | 540 | 340 | 429 |
| Debt incl. finance leases | 4,173 | 2,298 | 2,320 | 2,389 | 2,121 | 1,550 | 1,737 | 1,688 | 1,835 | 2,011 |
| Total assets | 9,189 | 10,244 | 7,953 | 8,320 | 8,713 | 9,392 | 8,220 | 7,248 | 7,114 | 7,015 |
| Total liabilities | 7,722 | 6,873 | 5,204 | 5,496 | 5,040 | 4,833 | 4,380 | 3,770 | 3,951 | 4,058 |
| Shareholders' equity | 1,287 | 2,620 | 2,520 | 2,687 | 3,519 | 4,378 | 3,624 | 3,251 | 2,959 | 2,750 |
| Margins and ratios | ||||||||||
| Gross margin | 20.2% | 24.1% | 23.2% | 20.3% | 18.0% | 20.6% | 19.3% | 14.8% | 14.3% | 13.2% |
| Operating margin | 8.8% | 10.7% | 10.9% | 6.9% | 8.0% | 9.5% | 8.4% | 1.4% | −0.4% | −2.3% |
| Net margin | 4.3% | 9.3% | 4.4% | 8.3% | 19.1% | 13.6% | 5.7% | 1.6% | −3.1% | −5.0% |
| Free cash flow margin | 10.2% | 14.4% | 12.6% | 9.2% | 0.3% | 8.2% | 8.0% | −0.3% | 1.3% | 2.0% |
| Return on capital | 8.9% | 13.4% | 15.6% | 10.0% | 8.5% | 13.4% | 9.9% | 0.9% | −0.4% | −2.2% |
| Return on equity | 23.9% | 32.6% | 13.1% | 21.6% | 33.3% | 26.5% | 11.5% | 2.9% | −6.1% | −9.9% |
| Return on assets | 3.4% | 6.5% | 3.7% | 6.9% | 12.1% | 11.5% | 5.2% | 1.3% | −2.6% | −4.0% |
| Net debt to EBITDA | 3.9x | 1.9x | 1.8x | 2.5x | 0.8x | 0.5x | 1.1x | 3.2x | 5.7x | 10.1x |